Tue, August 27, 2024
Mon, August 26, 2024
Fri, August 23, 2024
Thu, August 22, 2024

Keay Nakae Maintained (SONN) at Strong Buy and Held Target at $240 on, Aug 23rd, 2024


//stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-240-on-aug-23rd-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Keay Nakae of Chardan Capital, Maintained "Sonnet BioTherapeutics Holdings, Inc." (SONN) at Strong Buy and Held Target at $240 on, Aug 23rd, 2024.

Keay has made no other calls on SONN in the last 4 months.



There is 1 other peer that has a rating on SONN. Out of the 1 peers that are also analyzing SONN, 0 agree with Keay's Rating of Hold.



This is the rating of the analyst that currently disagrees with Keay


  • Tim Moore of "EF Hutton" Maintained at Strong Buy with Decreased Target to $56 on, Thursday, May 16th, 2024

Publication Contributing Sources